Health and Fitness Health and Fitness
Thu, March 1, 2012
[ Thu, Mar 01st 2012 ] - Market Wire
Pfizer, Silver Wheaton, Sodastream International, Las Vegas Sands, and Gentex
[ Thu, Mar 01st 2012 ] - Market Wire
Perrigo Announces the First Store Brand Launch of the Generic Version of Rogaine 5% Foam
[ Thu, Mar 01st 2012 ] - Market Wire
Southern Home Medical Provides Corporate Overview for Shareholders and Financial Industry
[ Thu, Mar 01st 2012 ] - Market Wire
NuVasive to Participate in Investor Events in March 2012
[ Thu, Mar 01st 2012 ] - Market Wire
Abbott to Build Nutrition Manufacturing Facility in Ohio
[ Thu, Mar 01st 2012 ] - Market Wire
Tibet Pharmaceuticals, Inc. Announces Receipt of .. g Privatequot;; Proposal at $3.00 Per Shar
[ Thu, Mar 01st 2012 ] - Market Wire
Hamilton Thorne Expands Distribution Partnership .. e and Optical Systems Producer Leica Microsystems
[ Thu, Mar 01st 2012 ] - Market Wire
Revealing an Innovative Corporate Structure Dedicated to Redefining Healthcare Value
[ Thu, Mar 01st 2012 ] - Market Wire
Boston Scientific Announces Launch of PROMUS Elementa" Platinum Chromium Stent System in Japan
[ Thu, Mar 01st 2012 ] - Market Wire
Cantel Medical Corp. to Hold Conference Call to D .. lts for Its Second Quarter Ended January 31, 2012
[ Thu, Mar 01st 2012 ] - Market Wire
Novelos Therapeutics and Academic Collaborators H .. pted for Presentation at 2012 AACR Annual Meeting
[ Thu, Mar 01st 2012 ] - Market Wire
Amica Mature Lifestyles Increases Ownership in Amica at Dundas
[ Thu, Mar 01st 2012 ] - Market Wire
Peregrine Announces Seven Abstracts Accepted for Presentation at AACR 2012 Annual Meeting
[ Thu, Mar 01st 2012 ] - Market Wire
Digirad Corporation Board of Directors Adopts Strengthened Charter and Policies
[ Thu, Mar 01st 2012 ] - Market Wire
Trimel Pharmaceuticals Corporation to Report Fina .. 11 and Host a Conference Call to Update Investors
[ Thu, Mar 01st 2012 ] - Market Wire
Herborium Group to Begin Commercialization of its .. roducts With Aggressive Plans to Take a Bite of a
[ Thu, Mar 01st 2012 ] - Market Wire
Omeros to Present at the Cowen and Company 32nd Annual Health Care Conference
[ Thu, Mar 01st 2012 ] - Market Wire
Novadaq Announces NASDAQ Listing
Wed, February 29, 2012
[ Wed, Feb 29th 2012 ] - Market Wire
Elan Chairman Provides Update on CEO Succession
[ Wed, Feb 29th 2012 ] - Market Wire
CML HealthCare Completes Refinancing of Credit Facility
[ Wed, Feb 29th 2012 ] - Market Wire
Hagens Berman Continues HMA Investigation, Reminds Investors 26 Days Remain Before Deadline
[ Wed, Feb 29th 2012 ] - Market Wire
SecureAlert Evaluates Historical Financials to Ensure Foundation for Expansion
[ Wed, Feb 29th 2012 ] - Market Wire
CONMED Corporation Announces Cash Dividend Policy and Declares Initial Quarterly Cash Dividend
[ Wed, Feb 29th 2012 ] - Market Wire
Lexicon Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference
[ Wed, Feb 29th 2012 ] - Market Wire
Anika Therapeutics Reports 25% Increase in Fourth-Quarter Revenue
[ Wed, Feb 29th 2012 ] - Market Wire
ProPhase Labs to Release Fourth Quarter Results on Tuesday, March 6th
[ Wed, Feb 29th 2012 ] - Market Wire
Phase III studies of Jakafia" (ruxolitinib) publi .. al of Medicine Demonstrate Significant Clinical B
[ Wed, Feb 29th 2012 ] - Market Wire
Nuvo Research announces 2011 fourth quarter & year-end results
[ Wed, Feb 29th 2012 ] - Market Wire
MEDNAX to Present at Raymond James 33rd Annual Institutional Investors Conference in Orlando, Fla.
[ Wed, Feb 29th 2012 ] - Market Wire
MannKind to Present at Cowen and Company 32nd Annual Health Care Conference

MannKind to Present at Cowen and Company 32nd Annual Health Care Conference


Published on 2012-02-29 14:15:52 - Market Wire
  Print publication without navigation


VALENCIA, Calif.--([ ])--MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at the Cowen and Company 32nd Annual Health Care Conference on March 7, 2012 at 10:40am Eastern at the Boston Marriott Copley Place in Boston, Massachusetts.

Interested parties can access a link to the live webcast of the presentations from the News & Events section of the Company's website at [ http://www.mannkindcorp.com ].

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. Its lead product candidate, AFREZZA, is in late stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. MannKind maintains a website at [ www.mannkindcorp.com ] to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.

Contributing Sources